Article from Clinical Evidence

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7334.428 (Published 16 February 2002) Cite this as: BMJ 2002;324:428

Cochrane review on IV β2 agonists for acute asthma was not mentioned

  1. Lars Christian Laursen (lclaursen@dadlnet.dk), doctor
  1. Department of Lung Diseases, KAS Gentofte, 2900 Hellerup, Denmark

    EDITOR—In the article from Clinical Evidence on acute asthma, FitzGerald claims that the effectiveness of intravenous versus nebulised delivery of short acting β2 agonists for acute asthma remains unknown.1 This statement is based on the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription